微信公众号

官网二维码

中国癌症防治杂志 ›› 2025, Vol. 17 ›› Issue (5): 619-626.doi: 10.3969/j.issn.1674-5671.2025.05.14

• 论著 • 上一篇    下一篇

葛根素对鼻咽癌细胞恶性生物学行为的影响及其分子机制

  

  1. 广西医科大学研究生院;广西医科大学附属武鸣医院肿瘤科
  • 出版日期:2025-10-25 发布日期:2025-12-03
  • 通讯作者: 赵伟 E-mail:zwei1112@126.com
  • 基金资助:
    广西中医药适宜技术开发与推广项目(GZSY22?70)

Impact of puerarin on malignant biological behaviour of nasopharyngeal carcinoma cells and its underlying molecular mechanisms#br#


  • Online:2025-10-25 Published:2025-12-03

摘要: 目的 探讨葛根素对鼻咽癌细胞增殖、迁移、侵袭和上皮⁃间质转化(epithelial⁃mesenchymal transition, EMT)的影响及其作用机制。方法 以不同浓度的葛根素处理鼻咽癌5⁃8F和HK⁃1细胞,使用CCK⁃8法筛选最佳干预浓度。将细胞分为阴性对照组、葛根素处理组,采用流式细胞术分析细胞周期变化情况,划痕实验检测细胞迁移情况,Transwell实验评估细胞侵袭能力。蛋白质印迹和免疫荧光技术定量分析EMT过程和PI3K/AKT/mTOR信号通路相关蛋白的表达。此外,PI3K激活剂740Y⁃P与葛根素联合处理5⁃8F和HK⁃1细胞,蛋白质印迹检测PI3K/AKT/mTOR信号通路相关蛋白的表达。CCK⁃8和克隆形成实验验证葛根素对肿瘤细胞增殖的抑制作用。 结果 鼻咽癌5⁃8F和HK⁃1细胞暴露于不同浓度葛根素(200~1 600 μmol/L)后,其存活率均显著降低(均P<0.0001),且呈剂量依赖性。与对照组相比,800 μmol/L和1 200 μmol/L葛根素均可显著抑制两种鼻咽癌细胞的增殖、迁移和侵袭能力(均P<0.001),阻滞细胞周期于G0/G1期(均P<0.05),增强EMT上皮标志物E⁃cadherin的蛋白表达,并降低间质标志物N⁃cadherin、Vimentin的蛋白表达。此外,葛根素下调了PI3K、AKT、mTOR及其磷酸化蛋白的表达水平,而PI3K激活剂740Y⁃P可逆转葛根素诱导的PI3K、AKT及mTOR的磷酸化水平变化,并减弱其对鼻咽癌细胞增殖的抑制作用(均P<0.01)。结论 葛根素可抑制鼻咽癌5⁃8F、HK⁃1细胞系增殖、迁移、侵袭和EMT,其机制可能通过调控PI3K/AKT/mTOR信号通路实现。

关键词: 鼻咽癌, 葛根素, 侵袭, 迁移, 上皮?间质转化

Abstract: Objective To investigate the impact of puerarin on the proliferation, migration, invasion, and epithelial⁃mesenchymal transition (EMT) in nasopharyngeal carcinoma cells, as well as to elucidate its potential mechanism. Methods Nasopharyngeal carcinoma 5⁃8F and HK⁃1 cells were exposed to varying concentrations of puerarin to identify the optimal concentration for intervention using the CCK⁃8 assay. The cells were divided into the negative control group and the puerarin group, receiving their respective treatments. Cycle progression was assessed by flow cytometry, cell migration was assessed via a scratch assay, and cell invasion was evaluated using a Transwell assay. Western blot and immunofluorescence assays were conducted to quantify the expression of proteins associated with the EMT process and the PI3K/AKT/mTOR signaling pathway. Furthermore, 5⁃8F and HK⁃1 cells were co⁃treated with the PI3K activator 740Y⁃P and puerarin, followed by Western blot analysis to detect the expression of proteins related to the PI3K/AKT/mTOR signaling pathway. The effects of puerarin on tumour cell proliferation were validated via CCK⁃8 assays, and clonogenic assays. Results The viability of nasopharyngeal carcinoma 5⁃8F and HK⁃1 cells was significantly reduced (all P<0.0001) upon exposure to varying concentrations (200-1,600 μmol/L) of puerarin, exhibiting a dose⁃dependent effect. Compared with the control group, puerarin at concentrations of 800 μmol/L and 1,200 μmol/L significantly suppressed the proliferation, migration, and invasion capabilities of nasopharyngeal carcinoma 5⁃8F and HK⁃1 cells (all P<0.001). Additionally, puerarin treatment resulted in cell cycle at the G0/G1 phase (all P<0.05), enhanced the protein expression levels of the epithelial marker E⁃cadherin, and reduced the protein expression levels of the mesenchymal markers N⁃cadherin and vimentin. Puerarin downregulated the expression of PI3K, AKT, mTOR and their phosphorylated forms, whereas the PI3K activator 740Y⁃P reversed the puerarin⁃induced changes in phosphorylation levels of PI3K, AKT and mTOR, and attenuated  the inhibitory effect of puerarin on nasopharyngeal carcinoma cell proliferation (all P<0.01).  Conclusions Puerarin inhibits the proliferation, migration, invasion, and EMT in nasopharyngeal carcinoma 5⁃8F and HK⁃1 cell lines, possibly by modulating the PI3K/AKT/mTOR signaling pathway. 

Key words: Nasopharyngeal carcinoma, Puerarin, Invasion, Migration, Epithelial? mesenchymal transition

中图分类号: 

  • R739.63